Skip to content
FDA Approves Second Monoclonal Antibody Medication for Alzheimer’s
1/9/23, 12:00 AM
FDA Approves Novel Rapid-Acting Oral Antidepressant
8/22/22, 12:00 AM
FDA Issues Warning About Dental Risk With Transmucosal Buprenorphine
1/14/22, 12:00 AM
Caplyta Approved for Bipolar Depression in Adults
12/20/21, 12:00 AM
Today Is Deadline to Recertify in Modified Clozapine REMS, Re-enroll Patients
11/15/21, 12:00 AM
FDA Narrows Use of New Alzheimer’s Drug to Early Stage Patients
7/9/21, 12:00 AM
Lybalvi Approved for Schizophrenia, Bipolar I Disorder in Adults
6/11/21, 12:00 AM
Alzheimer’s Antibody Therapy Receives Accelerated Approval Amid Controversy
6/8/21, 12:00 AM
FDA Authorizes Marketing of New Aid to Diagnose Autism
6/3/21, 12:00 AM
First
Prev
2
3
4
5
6
Next
Last
This is a search field with an auto-suggest feature attached.
There are no suggestions because the search field is empty.
Follow us on X
Follow us on Instagram
Follow us on LinkedIn
Follow us on YouTube
Sign up to receive each post directly into your inbox:
News From Current Issue
Special Report: Lithium Clinics and High-Risk Populations With Bipolar Disorder
Point/Counterpoint: Is Lithium the Gold Standard for Bipolar Disorder?
The War on SSRIs
Read This Week's Update
